These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21271268)

  • 1. Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods.
    Valenza G; Müller S; Schmitt C; Turnwald D; Lam TT; Frosch M; Abele-Horn M; Pfeifer Y
    Eur J Clin Microbiol Infect Dis; 2011 Jul; 30(7):869-72. PubMed ID: 21271268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases.
    Thomson KS; Cornish NE; Hong SG; Hemrick K; Herdt C; Moland ES
    J Clin Microbiol; 2007 Aug; 45(8):2380-4. PubMed ID: 17596369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods.
    Nyberg SD; Meurman O; Jalava J; Rantakokko-Jalava K
    Scand J Infect Dis; 2008; 40(5):355-62. PubMed ID: 17934979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.
    Morrissey I; Bouchillon SK; Hackel M; Biedenbach DJ; Hawser S; Hoban D; Badal RE
    J Med Microbiol; 2014 Apr; 63(Pt 4):556-561. PubMed ID: 24478449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative assessment of the Vitek 2 and Phoenix systems for detection of extended-spectrum beta-lactamases].
    Treviño M; Martínez-Lamas L; Romero-Jung P; Varón C; Moldes L; García-Riestra C; Regueiro BJ
    Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):566-70. PubMed ID: 19473732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test.
    Sanders CC; Barry AL; Washington JA; Shubert C; Moland ES; Traczewski MM; Knapp C; Mulder R
    J Clin Microbiol; 1996 Dec; 34(12):2997-3001. PubMed ID: 8940437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles].
    Oksüz L; Gürler N
    Mikrobiyol Bul; 2009 Apr; 43(2):183-94. PubMed ID: 19621602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-spectrum β-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system.
    Espinar MJ; Rocha R; Ribeiro M; Gonçalves Rodrigues A; Pina-Vaz C
    J Med Microbiol; 2011 Jun; 60(Pt 6):756-760. PubMed ID: 21330411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in Escherichia coli with CTX-M phenotypes.
    Donaldson H; McCalmont M; Livermore DM; Rooney PJ; Ong G; McHenry E; Campbell R; McMullan R
    J Antimicrob Chemother; 2008 Nov; 62(5):1015-7. PubMed ID: 18669518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the Phoenix automated microbiology system for detecting extended-spectrum beta-lactamase in Escherichia coli, Klebsiella species and Proteus mirabilis].
    Lee KK; Kim ST; Hong KS; Huh HJ; Chae SL
    Korean J Lab Med; 2008 Jun; 28(3):185-90. PubMed ID: 18594169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.
    Udomsantisuk N; Nunthapisud P; Tirawatanapong T; Dansuputra M
    J Med Assoc Thai; 2011 Dec; 94(12):1504-12. PubMed ID: 22295740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains.
    Dashti AA; West P; Paton R; Amyes SGB
    J Med Microbiol; 2006 Apr; 55(Pt 4):417-421. PubMed ID: 16533989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China.
    Li Y; Li Q; Du Y; Jiang X; Tang J; Wang J; Li G; Jiang Y
    J Clin Microbiol; 2008 Apr; 46(4):1317-21. PubMed ID: 18305137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The accuracy of extended-spectrum beta-lactamase detection in
    Young AL; Nicol MP; Moodley C; Bamford CM
    S Afr J Infect Dis; 2019; 34(1):114. PubMed ID: 34485454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of resistance and antibacterial susceptibility in extended-spectrum β-lactamase phenotype Klebsiella pneumoniae and Klebsiella oxytoca isolated between 2000 and 2010 in Japan.
    Sato T; Hara T; Horiyama T; Kanazawa S; Yamaguchi T; Maki H
    J Med Microbiol; 2015 May; 64(Pt 5):538-543. PubMed ID: 25813819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
    Park SD; Uh Y; Lee G; Lim K; Kim JB; Jeong SH
    APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency of extended-spectrum β-lactamase (ESBL) and AmpC β-lactamase genes in Escherichia coli and Klebsiella pneumoniae over a three-year period in a University Hospital in Korea].
    Li XM; Jang SJ; Bae IK; Park G; Kim YS; Shin JH; Moon DS; Park YJ
    Korean J Lab Med; 2010 Dec; 30(6):616-23. PubMed ID: 21157148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.